MarketPeel
Insider Trading Intelligence
CL

Column Group Iv, Lp

RAPT
10% OWNER · RAPT THERAPEUTICS, INC. · CIK 0001796354
FILING MIX · LIFETIME69%/31%
BUYS
20
SELLS
9
TOTAL VALUE
$51.81M
COMPANIES
2
ACTIVE SINCE
May 2022
HOLDINGS NOW
1,352,008
AVG SELL PX
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Column Group Iv, Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+3.79%-1.28%+5.08%+5.08%
14d3+100.00%+2.62%-0.17%+2.79%+2.79%
30d3+100.00%+2.83%-1.79%+4.62%+4.62%
60d3+0.00%-39.45%-4.55%-34.90%-34.90%
90d3+0.00%-36.76%+5.93%-42.69%-42.69%
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RAPT · 1,352,008 shares · as of Dec 23, 2024
0399,854799,7091,199,5631,599,41720232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 20 buys / 9 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EIKN
EIKON THERAPEUTICS, INC.
SALE
357,2160Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,437,323$18.00$25.87M4,312,139Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
110,9282,874,816Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
330,0000Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
688,283688,283Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
827,2780Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
630,881$18.00$11.36M1,319,164Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,403,5682,763,888Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,296,6291,360,320Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
28,2290Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
10,467,5260Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
9,670,0000Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
49,556$18.00$892.0K148,840Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
47,89895,499Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
3,78599,284Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
44,24947,601Feb 6, 2026Feb 9, 2026View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
5,133,0760Feb 6, 2026Feb 9, 2026View →
RAPT
RAPT THERAPEUTICS, INC.
SALE
1,599,4170Dec 23, 2024Dec 23, 2024View →
RAPT
RAPT THERAPEUTICS, INC.
SALE
1,352,00850,000Dec 23, 2024Dec 23, 2024View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,599,4171,599,417Dec 23, 2024Dec 23, 2024View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,352,0081,352,008Dec 23, 2024Dec 23, 2024View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,837$12.45$22.9K1,236,261May 25, 2022May 27, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
63$12.45$78542,189May 25, 2022May 27, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
15,776$12.00$189.3K1,234,424May 24, 2022May 25, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
538$12.00$6.5K42,126May 24, 2022May 25, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
9,898$12.50$123.7K1,218,648May 23, 2022May 25, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
338$12.50$4.2K41,588May 23, 2022May 25, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,208,750$10.67$12.90M1,208,750May 10, 2022May 12, 2022View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
41,250$10.67$440.2K41,250May 10, 2022May 12, 2022View →
Other insiders · RAPT
Loading peer insiders…
About this filer
CIK 0001796354
ROLE
10% Owner
PRIMARY
RAPT
COMPANIES
2
ACTIVE SINCE
May 2022
MARKETPEEL · /INSIDER/0001796354DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback